Gavin S. Herbert

This profile gathers the share dealings of Gavin S. Herbert in Allergan Inc. In total, 59 filings cover trades dated from 3 April 2006 to 2 May 2011.

The open-market side counts 7 purchases for €1.0M alongside 26 sales for €9.9M. On balance, insiders were net sellers of €8.9M. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. The rest of the record consists of 2 share grants and 3 option exercises. Since January 2011: no purchases and 6 sales on the market.

Half of the purchases are above €155k and half below.

Most recently, on 3 May 2011, the filings show an open-market sale worth €270k in Allergan Inc. The clock since the last published purchase (18 November 2008) now reads 6,564 days. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. US insiders must file a Form 4 within two business days of a trade. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.